Drug Industry Antitrust Act. hearings before the United States Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, Eighty-Seventh Congress, first session, on Dec. 7-9, 1961. Part 4, Pharmaceutical Manufacturers Association :

Continuation of hearings on S. 1552, the Drug Industry Antitrust Act, to make essential drugs available to the public at reasonable prices through the establishment of quality standards, periodic drug production inspections, and penalties for anticompetitive activities.